It seems that the rare earths prospect is no longer worthy of any progression. Best to open a new page and minimise money expended on that side of further exploration.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025